Loading...
Dapagliflozin
India Pharmaceutical Trade Intelligence
Who Supplies Dapagliflozin to India from SWEDEN
India's dapagliflozin imports from SWEDEN total $942.7K across 16 shipments from 3 foreign suppliers. ASTRAZENECA AB leads with $928.8K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ASTRAZENECA PHARMA INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for dapagliflozin — a concentrated sourcing relationship with select suppliers from SWEDEN.
Top foreign suppliers (SWEDEN) — Ranked by import value
ASTRAZENECA AB is the leading Dapagliflozin supplier from SWEDEN to India, with import value of $928.8K across 9 shipments. The top 5 suppliers — ASTRAZENECA AB, PRIVAPOSERVICES GMBH, SIA GP NORD — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (SWEDEN)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ASTRAZENECA AB | $928.8K | 9 | 98.5% |
| 2 | PRIVAPOSERVICES GMBH | $12.2K | 5 | 1.3% |
| 3 | SIA GP NORD | $1.7K | 2 | 0.2% |
Showing top 3 of 3 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from SWEDEN)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ASTRAZENECA PHARMA INDIA LIMITED | $928.8K | 9 | 98.5% |
| 2 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED | $8.5K | 3 | 0.9% |
| 3 | IPCA LABORATORIES LIMITED | $3.7K | 2 | 0.4% |
| 4 | INTAS PHARMACEUTICALS LTD | $1.7K | 2 | 0.2% |
Import Statistics
- Import Value
- $942.7K
- Shipments
- 16
- Foreign Suppliers
- 3
- Indian Buyers
- 4
- Avg. Shipment
- $58.9K
Other Dapagliflozin Import Origins
Related Analysis
Frequently Asked Questions — Dapagliflozin Imports from SWEDEN
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Dapagliflozin suppliers from SWEDEN to India?
The top Dapagliflozin suppliers from SWEDEN to India include ASTRAZENECA AB, PRIVAPOSERVICES GMBH, SIA GP NORD. The leading supplier is ASTRAZENECA AB with import value of $928.8K USD across 9 shipments. India imported Dapagliflozin worth $942.7K USD from SWEDEN in total across 16 shipments.
QHow much Dapagliflozin does India import from SWEDEN?
India imported Dapagliflozin worth $942.7K USD from SWEDEN across 16 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Dapagliflozin from SWEDEN?
The main Indian buyers of Dapagliflozin sourced from SWEDEN include ASTRAZENECA PHARMA INDIA LIMITED, CENTAUR PHARMACEUTICALS PRIVATE LIMITED, IPCA LABORATORIES LIMITED. The largest buyer is ASTRAZENECA PHARMA INDIA LIMITED with $928.8K in imports across 9 shipments.
QWhat is the total value of Dapagliflozin imports from SWEDEN to India?
The total value of Dapagliflozin imports from SWEDEN to India is $942.7K USD, across 16 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: SWEDEN to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Dapagliflozin.
- 2.Supplier/Buyer Matching: 3 foreign suppliers from SWEDEN and 4 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $942.7K aggregated from 16 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
3 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists